| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President &CEO | Head Of Research &Development +4 more
2 companies
Sandrock Alfred is a President And CEO at Voyager Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | VYGR Voyager Therapeutics, Inc. | President And CEO | Sell | 14,197 | $3.79 | $53,806.63 | -2.8% | - | - | |
| Feb 10, 2026 | VYGR Voyager Therapeutics, Inc. | President And CEO | Sell | 12,192 | $3.78 | $46,085.76 | -2.3% | +9.5% | - | |
| Apr 2, 2025 | VYGR Voyager Therapeutics, Inc. | President And CEO | Sell | 10,885 | $3.43 | $37,335.55 | -2.5% | -8.5% | +16.1% | |
| Feb 20, 2025 | VYGR Voyager Therapeutics, Inc. | President And CEO | Sell | 11,702 | $4.24 | $49,616.48 | -3.8% | -26.1% | -18.1% | |
| Feb 11, 2025 | VYGR Voyager Therapeutics, Inc. | President &CEO | Sell | 16,644 | $4.45 | $74,065.80 | -5.1% | -20.3% | -13.2% | |
| Apr 2, 2024 | VYGR Voyager Therapeutics, Inc. | President And CEO | Sell | 12,115 | $9.86 | $119,453.90 | -3.6% | -20.7% | -65.6% | |
| Feb 21, 2024 | VYGR Voyager Therapeutics, Inc. | President And CEO | Sell | 13,033 | $7.46 | $97,226.18 | -3.7% | +10.5% | -44.2% | |
| Apr 3, 2023 | VYGR Voyager Therapeutics, Inc. | President And CEO | Sell | 7,437 | $7.83 | $58,231.71 | -3.3% | +38.5% | +22.0% | |
| Jun 7, 2021 | BIIB Biogen Inc. | Head Of Research &Development | Sell | 7,672 | $440.00 | $3,375,680.00 | -43.0% | -17.3% | -49.2% | |
| Nov 4, 2020 | BIIB Biogen Inc. | EVP, Research &Development | Sell | 1,500 | $350.00 | $525,000.00 | -10.3% | - | - |